rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Ralliant Corporation

RAL · NYSE

Health CareLife-science toolsLeadingDefense-Tech

RAL stood above a rising 150-day average in 25 of the last 34 weekly readings, including each of the last 24 weeks. It is 9.3% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
24 in a row
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$1.0M
Insider sales, 12 months
$9.4M
Officials’ trades on record
9
Institutions holding
497 (+43)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 25 of 34 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$3.2M$0$865KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

9 disclosed lines: House 2, Senate 0, executive 7; 2 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k29 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k22 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k15 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k30 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k4 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k2 Feb 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k30 Jan 2026filed 14 May 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$15k–$50k9 Jul 2025filed 14 Aug 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$15k–$50k8 Jul 2025filed 12 Sep 2025

Insiders

Buy orders, 12 months6
Sale orders, 12 months7
Buyers · sellers6 · 3
WhoDidSharesTraded
Tamara S. NewcombePresident and CEOsold12,936at $70.5814 Oct 2026filed 16 Oct 2026
Tamara S. NewcombePresident and CEOsold12,936at $65.3014 Sep 2026filed 16 Sep 2026
Karen M. BickSVP - Chief People Officersold6,062at $72.0017 Aug 2026filed 18 Aug 2026
Tamara S. NewcombePresident and CEOsold12,936at $71.7914 Aug 2026filed 18 Aug 2026
Teo OsbenChief Accounting Officersold27,058at $62.4428 May 2026filed 1 Jun 2026
Karen M. BickSVP - Chief People Officersold2,530at $46.505 Mar 2026filed 9 Mar 2026
Karen M. BickSVP - Chief People Officersold5,485at $45.003 Mar 2026filed 5 Mar 2026
Kate MitchellDirectorbought2,350at $42.4810 Feb 2026filed 12 Feb 2026
Anelise Angelino SacksDirectorbought2,000at $41.259 Feb 2026filed 10 Feb 2026
Ganesh MoorthyDirectorbought2,000at $39.746 Feb 2026filed 9 Feb 2026
Brian WorrellDirectorbought2,500at $39.936 Feb 2026filed 9 Feb 2026
Amir A. KazmiSVP - Chief Technology Officerbought2,545at $39.276 Feb 2026filed 9 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders497+43 on the quarter
New · exited108 · 64
Reported value$8.0B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202614,117,630$1.0B+574,577+4.2%
Dodge & Coxadded · filed 13 Aug 202614,005,203$1.0B+257,652+1.9%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20267,676,579$565.2M-778,674−9.2%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20265,056,526$372.3M-10,726−0.2%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 20264,504,829$331.7M+143,152+3.3%
STATE STREET CORPadded · filed 7 Aug 20263,822,557$281.4M+143,713+3.9%
FLOSSBACH VON STORCH SEreduced · filed 10 Aug 20263,021,324$222.5M-685,561−18.5%
MORGAN STANLEYadded · filed 13 Aug 20262,365,461$174.2M+777,864+49.0%
FULLER & THALER ASSET MANAGEMENT, INC.new · filed 12 Aug 20262,255,379$166.1M+2,255,379
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPadded · filed 13 Aug 20261,937,397$142.7M+473,619+32.4%
30 Jun 2025 – 30 Jun 2026
456476495Jun 25Sep 25Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Tamara S. Newcombe Company insiderPresident and CEO · last 14 Oct 20260 · 3
Amir A. Kazmi Company insiderSVP - Chief Technology Officer · last 23 Sep 20261 · 0
Jonathon E. Boatman Company insiderSVP - Chief Legal Officer · last 23 Sep 20260 · 0
Karen M. Bick Company insiderSVP - Chief People Officer · last 23 Sep 20260 · 3
Neill Reynolds Company insiderSVP - Chief Financial Officer · last 23 Sep 20260 · 0
Teo Osben Company insiderChief Accounting Officer · last 23 Sep 20260 · 1
Donald J. Trump Executive branchWhite House Office · last 29 Jul 20265 · 2
Alan G. Spoon Company insiderDirector · last 5 Jun 20260 · 0
Anelise Angelino Sacks Company insiderDirector · last 5 Jun 20261 · 0
Brian Worrell Company insiderDirector · last 5 Jun 20261 · 0
Ganesh Moorthy Company insiderDirector · last 5 Jun 20262 · 0
Kate Mitchell Company insiderDirector · last 5 Jun 20261 · 0

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202550.3%
Operating profit marginFY 2025 · to 31 Dec 2025-57.2%
Free cash flow marginFY 2025 · to 31 Dec 202517.3%
Return on capital employedFY 2025 · to 31 Dec 2025-44.4%
Debt to equityFY 2025 · to 31 Dec 20251.03×
Research spendFY 2025 · to 31 Dec 20258.0%
Dividend growthFY 2025 · to 31 Dec 2025100%
Share count trendFY 2025 · to 23 Feb 2026-1.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$318.8M
Free cash flowFY 2025 · to 31 Dec 2025$358.4M

Analyst forecasts

No analyst forecasts yet.